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Introduction {#sec1}
============

β Cell replacement therapy is an attractive therapy to achieve normoglycemia in patients with diabetes mellitus due to severe β cell failure ([@bib36], [@bib41]). The shortage of organ donors severely limits the number of patients that are eligible for current β cell replacement therapy, i.e., pancreas or islet transplantation. Mature human β cells cannot be expanded *in vitro* without complex dedifferentiation and redifferentiation processes ([@bib43], [@bib14]). Thus, there is an unmet clinical need to generate insulin-producing cells from alternative cell sources to make this therapy more widely available.

Several types of cells have been studied as possible sources of insulin-producing cells, including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (iPSCs). While the phenotype of these cells has long been characterized by immature maturation ([@bib17]), recently more glucose-responsive cells have been generated from human pluripotent stem cells *in vitro* ([@bib39], [@bib40]), but safety remains a major concern for any regenerative strategy using hESCs or iPSCs ([@bib33], [@bib35]). An attractive alternative could be the use of putative progenitor cells from adult human pancreas that give rise to the endocrine lineage. Histological studies of human pancreas indicate that neogenesis of insulin-producing cells is associated with the ductal tree in obesity and pregnancy ([@bib6], [@bib7]). Other studies have also shown that some insulin-producing cells can be generated from cultured human pancreatic ductal tissue ([@bib5], [@bib51], [@bib30], [@bib26]). We recently showed that *in silico* analysis of single-cell transcriptome profiles of human adult pancreatic cells using a StemID algorithm predicts a distinct subpopulation of ductal cells with multipotential differentiation potential ([@bib16]). In mice, the existence of postnatal endocrine progenitors within the pancreatic ductal population has become controversial, with lineage-tracing experiments showing contradictory results. Although several studies were able to detect endocrine cells derived from the ductal lineage postnatally or after injury ([@bib21], [@bib50], [@bib10], [@bib1]), others did not find this ([@bib48], [@bib28], [@bib11]).

At present, expansion of human pancreatic cells in a standard, 2D culture system is hampered by the transition of both islet ([@bib44], [@bib14]) and duct cells ([@bib12], [@bib46], [@bib49]) to a mesenchymal cell-like phenotype during passaging. This approach does not provide the natural 3D environment of tissues, and thus important information of cell orientation and polarity for proliferation, growth, and differentiation are lost. In fact, proper alignment and polarization of progenitor cells is known to be required for successful differentiation of fetal pancreatic progenitor cells ([@bib25], [@bib9]), and 3D culture of fetal murine pancreatic progenitors can be used to unravel and mimic niches important in pancreas development ([@bib15]). Thus, it is tempting to hypothesize that 3D culture of adult human pancreatic tissue may provide a microenvironment that enhances expansion and differentiation of pancreatic progenitors.

A Matrigel-based 3D culture system was developed in our institute that yields organoids from stem cells in different organs, with the capacity for long-term expansion and generation of functional differentiated organ-specific cells ([@bib45], [@bib18], [@bib19]). Single isolated adult mouse pancreatic progenitor cells can be expanded by forming colonies or organoids in a Matrigel-based system ([@bib15], [@bib18], [@bib24]). We observed that these progenitor cells are derived from the ductal tree, express the stem cell marker leucine-rich repeat containing G protein-coupled receptor 5 (*Lgr5*) in culture and are able to differentiate toward the endocrine lineage ([@bib18]).

Results {#sec2}
=======

Human Pancreatic Tissue Expands as Budding Organoids {#sec2.1}
----------------------------------------------------

Islet-depleted pancreatic tissue after collagenase digestion was obtained from 35 non-diabetic organ donors (age 53.6 ± 12.1 years and BMI 24.7 ± 4.0 kg/m^2^) and one organ donor with a history of type 1 diabetes (age 48 years, BMI 21 kg/m^2^). After mechanical dissociation the small clumps of tissue were embedded in Matrigel and supplied with an epidermal growth factor/Noggin/R-spondin-based expansion medium. More than 90% of small pancreatic cell clusters formed budding structures within 3 days ([Movie S1](#mmc2){ref-type="supplementary-material"}), and expanded with a cauliflower-like appearance by day 7 ([Figure 1](#fig1){ref-type="fig"}A). Some larger cyst-like structures were present in the organoids ([Figure 1](#fig1){ref-type="fig"}A). Organoids could be passaged without macroscopic changes in phenotype ([Figure 1](#fig1){ref-type="fig"}B), and maintained in culture for at least 10 passages ([Figure 1](#fig1){ref-type="fig"}C). The calculated rate for cell doubling was ∼67 hr during passage 0 (P0) (n = 3). Growth rate slightly diminished upon passaging ([Figure 1](#fig1){ref-type="fig"}C). The proportion of small budding structures and cyst-like structures varied among donors ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Organoids could also be generated from pancreatic tissue from an organ donor with a history of type 1 diabetes ([Figure S1](#mmc1){ref-type="supplementary-material"}B).Figure 1Characterization of Human Pancreatic Organoids during Expansion in a 3D Culture System(A) Bright-field image of pancreatic organoids (P0), expanded for 7 days in a 3D Matrigel-based culture system, reveals extensive growth with multiple budding structures. Some larger buds have a cyst-like appearance. The insert shows a close-up image of the cell lining (between arrowheads) in a budding structure. Scale bar, 100 μm.(B) Passaged organoids (P1 and P3 are shown) expanded in similar conditions as P0 (A), also forming budding structures in a cauliflower-like configuration. Scale bar, 100 μm.(C) Growth curve of pancreatic organoids cultured for 140 days. Cell numbers were counted on days 0, 4, and 7 (P0), and at the end of subsequent passages. Cells in five wells per time point were counted (mean ± SEM). The expansion curve is representative of n = 3 donors.(D) Quantification of number of cells positive for INS, GCG, AMY, or KRT19 by immunohistochemistry in organoids on day 7 of expansion culture (n = 8 donors; at least 10 organoids/donor were counted; mean ± SEM). DAPI was used as nuclear counterstain.(E) Non-passaged organoids (P0, upper panels) have similar features compared with passaged organoids (P3, lower panels). Left panels: the majority of the cells are KRT19^+^ (green), with no INS^+^ cells (red) detected during the expansion phase. Middle panels: MUC1 (green) staining at the apical cell border indicates polarization of the duct cells. Small lumena are visible within the organoids (arrowheads). Right panels: few vimentin-positive (VIM^+^) cells (green) are present in the organoids (arrowheads). n = 5 donors; \>15 organoids/donor were stained. DAPI was used as nuclear counterstain. Scale bars, 50 μm. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Next, we analyzed the cellular composition of organoids in the expansion phase. At day 7 (P0), 92.3% ± 5.4% of organoid cells were positive for the epithelial marker keratin 19 (KRT19), indicating a ductal phenotype ([Figures 1](#fig1){ref-type="fig"}D and 1E). Also at passage 3 (P3), the vast majority of the cells still had a ductal phenotype (87.2% ± 8.4% of organoid cells were KRT19^+^). No insulin-positive (INS^+^), glucagon-positive (GCG^+^), or amylase-positive (AMY^+^) cells were detected in the organoids at day 7 of the expansion phase (P0) ([Figures 1](#fig1){ref-type="fig"}D and 1E). The organoids were organized as KRT19^+^ cells lining cystic or smaller elongated luminal spaces ([Figure 1](#fig1){ref-type="fig"}E). In both early and late passages, cells appeared polarized with positive mucin-1 (MUC1) staining at the luminal side of the KRT19^+^ epithelial lining ([Figure 1](#fig1){ref-type="fig"}E). Although human pancreatic cells in 2D culture systems acquire a mesenchymal cell-like phenotype ([@bib14], [@bib12], [@bib46], [@bib49], [@bib38]), few vimentin-positive cells (\<2%) were observed in our organoid cultures at P0 or P3 ([Figure 1](#fig1){ref-type="fig"}E). Thus, small adult human pancreatic cell clusters can be expanded and passaged in 3D culture, generating polarized ductal budding structures.

Human Pancreatic Organoids Display Pancreatic Progenitors Clustered toward the Tips of the Budding Structures {#sec2.2}
-------------------------------------------------------------------------------------------------------------

Since extensive growth by budding was observed, we determined the proliferative capacity of the budding structures. Quantification showed that 27.3% ± 8.7% of the cells within an organoid were Ki67^+^ at day 7 of expansion ([Figure 2](#fig2){ref-type="fig"}A). Only a few Ki67^+^ cells were negative for the duct marker KRT19 (1.3% ± 0.8% of Ki67^+^ cells). Ki67^+^ cells were mainly observed in tips of buds and were not frequently observed in trunk regions ([Figure 2](#fig2){ref-type="fig"}B). Also, budding structures with wide tips and narrow trunks were present in the organoids ([Figures 2](#fig2){ref-type="fig"}B and 2C). Labeling with the nucleoside analog 5-ethynyl-2′-deoxyuridine that incorporates into newly synthesized DNA further confirmed the location of the proliferative cells toward the tip region (data not shown).Figure 2Tips of Budding Structures of Pancreatic Organoids Contain Cells with Progenitor Cell Characteristics(A) Quantification of cells positive for pancreatic progenitor and proliferation markers in organoids on day 7 of expansion culture. Organoids derived from four to six donors were analyzed (at least ten organoids/donor). Data are expressed as mean ± SEM.(B) Confocal image of pancreatic organoids on day 7 of expansion. Top: organoids were stained for the proliferation marker Ki67 (green) and ductal marker KRT19 (red). Organoid budding structures show a narrow trunk region (arrowhead) and a wider tip region (arrow). Bottom: organoids were stained for SOX9 (red) and PDX1 (green). SOX9^+^ cells were present both in the buds and in the trunk region of the organoids (arrowhead). PDX1^+^ cells (green), which frequently co-expressed SOX9 (yellow), were mainly located in the budding structures with strong staining for PDX1 often observed in cells at the outermost tip regions (arrow). Both overlay and individual channels are depicted. DAPI was used as nuclear counterstain. Scale bars, 100 μm.(C) Organoids in expansion phase for 7 days were labeled with the Aldefluor fluorescent reagent system, marking progenitor cells characterized by high ALDH activity. Most ALDH^hi^ cells (green) were located in the tips of organoid buds. Scale bar, 50 μm.(D) FACS analysis of dispersed organoid cells (after 7 days in expansion culture) labeled with Aldefluor with and without the ALDH inhibitor DEAB. The FACS plot shows how ALDH^hi^ cells (i.e., cells that express high ALDH activity) and ALDH^lo^ cells (i.e., cells that express low ALDH activity) are selected. Representative plot from n = 10 donors.(E) Bright-field images of sorted and expanded single ALDH^lo^ cells (left panel) and ALDH^hi^ cells (right panel) in Matrigel for 14 days. Scale bar, 100 μm.(F) Proportion of sorted ALDH^lo^ and ALDH^hi^ cells with colony-forming (organoid-forming) potential. Data represent mean ± SEM (n = 3 donors).(G) Gene expression of *CPA1, PTF1A, MYC*, and *PDX1* in sorted ALDH^lo^ and ALDH^hi^ cells derived from organoids expanded for 7 days. The graph shows the gene expression ratio in ALDH^hi^ to ALDH^lo^ cells for the different markers. Mean ± SEM (n = 3 donors) ^∗^p \< 0.05.(H) Whole-mount immunostaining for ALDH1A1 and CPA1 of organoids expanded for 7 days. Confocal images show ALDH1A1^+^ cells (green) and CPA1^+^ cells (red) in the tip of the budding structures. Some cells co-express the two markers. Scale bar, 50 μm.CFU, colony-forming unit. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

Based on the configuration of the budding structures, we hypothesized that the tips of the budding structures would be enriched for pancreatic progenitor cells, as has been reported for mouse fetal pancreatic development ([@bib52], [@bib47]). Immunostaining of the organoids for the pancreatic progenitor markers pancreatic and duodenal homeobox 1 (PDX1) and SRY (sex-determining region Y) box 9 (SOX9) ([Figure 2](#fig2){ref-type="fig"}B) showed high PDX1 expression in the budding structures of the organoids, particularly in tip regions, while SOX9 was more homogeneously distributed ([Figure 2](#fig2){ref-type="fig"}B). *SOX9* and *PDX1* gene expression increased during expansion ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Furthermore, gene expression of *LGR5* increased during this time ([Figure S2](#mmc1){ref-type="supplementary-material"}B), and a subset of cells in budding structures clearly expressed *LGR5* mRNA, as assessed by smFISH ([Figure S2](#mmc1){ref-type="supplementary-material"}C). No neurogenin-3-positive (NEUROG3^+^) cells were observed in organoids in the expansion phase ([Figure 2](#fig2){ref-type="fig"}A). Next, we exposed the organoids to a fluorescent reagent (Aldefluor) that identifies progenitor cells based on their increased aldehyde dehydrogenase activity (ALDH) activity. Pancreatic progenitors with high expression of ALDH1 isoforms have recently been identified in both developing and adult mouse pancreas ([@bib22], [@bib42]). Cells concentrated in the tips of the budding structures showed high ALDH activity ([Figure 2](#fig2){ref-type="fig"}C). The Aldefluor reagent is optimized to detect enzyme activity of ALDH1 isoforms, and we found that ALDH1A1 immunostaining co-localized with both KRT19^+^ and KRT19^−^ cells in the tips of the organoid buds, indicating the presence of heterogeneous populations of ALDH1A1^+^ cells (data not shown). High ALDH activity arose during organoid culture as no ALDH^hi^ cells were found in the d0 islet-depleted tissue (n = 3; data not shown). *LGR5* gene expression was higher in sorted ALDH^hi^ compared with ALDH^lo^ cells ([Figure S2](#mmc1){ref-type="supplementary-material"}D).

Single ALDH^hi^ Cells Show Progenitor Characteristics {#sec2.3}
-----------------------------------------------------

To determine whether ALDH^hi^ cells have characteristics of progenitor cells, organoids were dispersed into single cells, labeled with Aldefluor, and sorted by fluorescence-activated cell sorting (FACS) (ALDH^lo^ cells 34.0% ± 7.4% and ALDH^hi^ cells 25.4% ± 6.0%, n = 5) ([Figure 2](#fig2){ref-type="fig"}D). A subpopulation of ALDH^hi^ cells derived from organoids was able to generate small cyst-like colonies in 3D culture (2.2% ± 0.8% of ALDH^hi^ cells), in marked contrast to ALDH^lo^ cells that formed no colonies ([Figures 2](#fig2){ref-type="fig"}E, 2F, and [S3](#mmc1){ref-type="supplementary-material"}A). When organoids derived from single-sorted ALDH^hi^ cells were immunostained for ALDH1A1, both ALDH1A1^+^ and ALDH1A1^−^ cells were observed, indicating the generation of a heterogeneous cell population from a single ALDH^hi^ cell ([Figure S3](#mmc1){ref-type="supplementary-material"}B). When these labeled organoids were sorted once more, yet again only ALDH^hi^ cells showed colony-forming potential in 3D culture (data not shown). Interestingly, complex budding structures were not observed when single ALDH^hi^ cells were expanded, which could indicate the requirement of supporting cells for self-assembly into a ductal-tree-like configuration ([Figure S3](#mmc1){ref-type="supplementary-material"}A).

Next, we characterized the ALDH^hi^ cell population for the presence of markers previously described for multipotent progenitor cells in mouse pancreatic organogenesis ([@bib52]). Gene expression levels of the markers carboxypeptidase A1 (*CPA1*) and pancreas-specific transcription factor, 1a (*PTF1A*) were significantly upregulated in ALDH^hi^ cells compared with the ALDH^lo^ fraction ([Figure 2](#fig2){ref-type="fig"}G). Immunoreactivity for CPA1 was found in ALDH1A1^+^ cells in the tips of organoid budding regions, but some ALDH1A1^+^ cells were CPA1^−^ ([Figure 2](#fig2){ref-type="fig"}H). Importantly, these ALDH1A1^+^ cells were negative for the acinar cell marker amylase ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Many ALDH1A1^+^ cells in the tips of budding regions buds also co-stained for PDX1 ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Genes that are known to be upregulated in mouse centroacinar (CAC) cells, such as *HES1*, *SOX9*, *SCA1*, *MET*, *NES*, and *HEY1* ([@bib42], [@bib27]), were analyzed in sorted ALDH^hi^ and ALDH^lo^ cells. No upregulation of these markers was present in ALDH^hi^ compared with ALDH^lo^ cells ([Figure S3](#mmc1){ref-type="supplementary-material"}E). HES1^+^ cells were present in expanded organoids after 7 days, but their distribution was not well defined ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Thus, a subpopulation of ALDH^hi^ cells within human pancreatic organoids has colony formation capacity and expresses pancreatic progenitor markers.

Transcriptional Profiling Shows Clustering of ALDH^hi^ Cells from Adult and Fetal Pancreatic Organoids {#sec2.4}
------------------------------------------------------------------------------------------------------

Since the self-assembly of adult human pancreatic tissue into organoids in our 3D culture system resembles budding structures previously described in pancreatic development, we compared characteristics of organoids derived from adult pancreatic tissue (adult pancreatic organoids) with human fetal pancreatic tissue and organoids derived from this fetal pancreatic tissue (fetal pancreatic organoids). We observed that fetal pancreatic organoids displayed a similar morphology to adult pancreatic organoids under the same culture conditions ([Figure 3](#fig3){ref-type="fig"}A). ALDH^hi^ cells were predominantly located in budding structures ([Figure 3](#fig3){ref-type="fig"}A). This observation strengthened our hypothesis that ALDH^hi^ cells that are concentrated in tip regions have pancreatic progenitor characteristics. We set out to determine the level of similarity of these putative ALDH^hi^ progenitors isolated from adult pancreatic organoids with ALDH^hi^ cells derived from fetal pancreatic organoids. Global gene expression analysis revealed that ALDH^hi^ cells from adult pancreatic organoids are transcriptionally closer to ALDH^hi^ cells isolated from fetal pancreatic organoids than to the adult exocrine tissue they originated from ([Figures 3](#fig3){ref-type="fig"}B and 3C). In contrast, ALDH^hi^ cells from fetal pancreatic organoids retained their more primitive identity, clustering closely to fetal pancreatic tissue ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, expression levels of the multipotent progenitor markers *CPA1*, *PTF1A, PDX1,* and *MYC* in ALDH^hi^ cells from adult pancreatic organoids were comparable with those in ALDH^hi^ cells from organoids derived from fetal pancreas (no significant difference, p \< 0.05; data not shown).Figure 3Transcriptional Profiling Shows Clustering of ALDH^hi^ Cells from Adult and Fetal Pancreatic Organoids(A) Aldefluor labeling of adult and fetal human pancreatic organoids expanded for 7 days. Maximum projection (confocal imaging). Scale bar, 100 μm.(B) Principal-component analysis for gene expression profiles of the following samples: A1--A3: ALDH^hi^ cells sorted from organoids after 7 days expansion derived from human adult pancreatic tissue (age 50.0 ± 18.7 years, BMI 22.0 ± 4.0 kg/m^2^). F1--F3: ALDH^hi^ cells sorted from organoids after 7 days expansion derived from human fetal pancreatic tissue (gestational age: F1 9 weeks, F2 20 weeks, and F3 22 weeks). P1--P4: primary fetal pancreatic tissue (gestational age: P1 9 weeks, P2 18 weeks, P3 14 weeks, and P4 10 weeks). I1--I4: adult human islets (age 34.5 ± 17.3 years, BMI 23.8 ± 4.5 kg/m^2^). E1--E4: adult exocrine (islet-depleted) pancreatic tissue (age 63.5 ± 5.7 years, BMI 25.5 ± 3.7 kg/m^2^).(C) Correlation cluster analysis for the gene expression profiles of the samples described in (B).

Pancreatic Organoids Can Differentiate toward an Endocrine Fate *In Vitro* {#sec2.5}
--------------------------------------------------------------------------

Since pancreatic organoids expanded from adult human exocrine tissue express progenitor markers during expansion, their differentiation potential was studied using culture conditions reported to differentiate human duct cells ([@bib51], [@bib13]). When P0 organoids were transferred to low attachment plates containing differentiation medium, their budding structure appeared to collapse and a rounded shape was seen after 7 days ([Figure 4](#fig4){ref-type="fig"}A). By then, growth had almost completely stopped as indicated by the near absence of Ki67^+^ cells (0.9% ± 0.4% of total cells; [Figures 4](#fig4){ref-type="fig"}B and 4H) and reduced Cyclin D1 (*CCND1*) gene expression ([Figure 4](#fig4){ref-type="fig"}G). Furthermore, the proportion of ALDH1A1^+^ cells decreased considerably from 27.0% ± 14.5% (P0 expansion day 7) to 1.4% ± 1.3% of total cells (differentiation day 7) ([Figure 4](#fig4){ref-type="fig"}H).Figure 4Endocrine Cell Markers in Pancreatic Organoids after 7 Days of *In Vitro* Differentiation(A) Bright-field image of human pancreatic organoids initially expanded for 7 days followed by differentiation culture for 7 days. DAPI was used as nuclear counterstain. Scale bar, 100 μm.(B) Confocal image of pancreatic organoids immunostained for Ki67 (green) and KRT19 (red). The majority of cells were KRT19^+^. No cells were Ki67^+^. DAPI was used as nuclear counterstain. Scale bar, 50 μm.(C) Confocal image of pancreatic organoids immunostained for KRT19 (green) and INS (red). Few INS^+^ (0.52%) cells were present. DAPI was used as nuclear counterstain. Scale bar, 50 μm.(D) Confocal image of pancreatic progenitor markers PDX1 (green) and SOX9 (red). DAPI was used as nuclear counterstain. Scale bar, 50 μm.(E) Confocal image of pancreatic progenitor marker NEUROG3 (red). DAPI was used as nuclear counterstain. Scale bar, 50 μm.(F) Confocal image of pancreatic progenitor marker NKX6.1 (green). DAPI was used as nuclear counterstain. Scale bar, 50 μm.(G) Gene expression of several markers in organoids on day 7 of differentiation compared with organoids on day 7 of expansion. Gene expression in expansion organoids were set to 1 (dotted line). Mean ± SEM, n = 8 donors. ^∗^p \< 0.05 and ^∗∗^p \< 0.01.(H) Percentage of cells immunostained for different markers on day 7 of expansion (white bars) compared with day 7 of differentiation (black bars) using confocal images. More than 10 organoids per donor were assessed. Mean ± SEM, n = 4--6 donors. ^∗^p \< 0.05 and ^∗∗^p \< 0.01.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

A marked increase in insulin gene expression after 7 days of differentiation was observed when compared with the end of the expansion phase ([Figure 4](#fig4){ref-type="fig"}G). Despite the considerable increase in insulin gene expression with differentiation, few INS^+^ cells were observed by immunostaining (0.52% ± 0.22%; [Figures 4](#fig4){ref-type="fig"}C and 4H). *GCG* gene expression was only slightly increased between expansion and differentiation ([Figure 4](#fig4){ref-type="fig"}G), and no GCG^+^ cells were present in the differentiation phase ([Figure 4](#fig4){ref-type="fig"}H). To exclude the possibility that insulin was taken up from the medium, we confirmed that INS^+^ cells were also positive for human C-peptide ([Figure S4](#mmc1){ref-type="supplementary-material"}A). No AMY^+^ cells were observed and the majority of cells remained KRT19^+^ during differentiation (83.4% ± 14.5% of cells; [Figure 4](#fig4){ref-type="fig"}H), even though gene expression of *KRT19* decreased ([Figure 4](#fig4){ref-type="fig"}G).

Gene expression of the endocrine progenitor marker *NEUROG3* and β cell marker NKX 6 homeobox 1 (*NKX6.1*) were significantly upregulated during the differentiation phase ([Figure 4](#fig4){ref-type="fig"}G). NEUROG3^+^ cells could also be identified by immunostaining in the "collapsed" organoids ([Figures 4](#fig4){ref-type="fig"}E and 4H). In addition, more cells expressed NKX6.1 in the differentiation phase compared with the expansion phase ([Figures 4](#fig4){ref-type="fig"}F and 4H). Conversely, no change was found in gene expression of the pancreatic progenitor markers *PDX1* and *SOX9* upon differentiation ([Figure 4](#fig4){ref-type="fig"}G) or the number of PDX1^+^ and SOX9^+^ cells ([Figures 4](#fig4){ref-type="fig"}D and 4H). Thus, upon *in vitro* differentiation, pancreatic progenitors can be directed along the endocrine lineage.

Human Pancreatic Tissue Can Be Cryopreserved without Losing Expansion or Differentiation Capacities {#sec2.6}
---------------------------------------------------------------------------------------------------

With therapeutic purposes in mind, we explored the possibility of cryopreserving pancreatic tissue before organoid expansion. Freshly retrieved tissue (day 0) was compared with cryopreserved tissue (day 0) from the same donors (n = 4). Growth of organoids with budding structures was observed from both groups ([Figure S4](#mmc1){ref-type="supplementary-material"}B), but the organoids grown from cryopreserved starting material had more cystic appearance than organoids grown from freshly isolated material. When subjected to *in vitro* differentiation, no significant differences in gene expression were found ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Thus, organoids can be grown from cryopreserved primary human adult pancreatic tissue.

Human Pancreatic Organoids Generate Insulin-Producing Cells *In Vivo* {#sec2.7}
---------------------------------------------------------------------

While the *in vitro* differentiation experiments indicated differentiation toward an endocrine lineage based on gene expression analysis, only a few INS^+^ cells were observed. It is well known that human ESC differentiate into insulin-producing cells after implantation into mice ([@bib29]). Therefore, we tested the capacity of pancreatic organoids to further differentiate *in vivo* after transplantation under the kidney capsule of immunodeficient mice. One day after transplantation the majority of grafted cells were KRT19^+^ and no INS^+^ cells were observed ([Figure 5](#fig5){ref-type="fig"}A). However, pancreatic organoids from the same donor 1 month after transplantation showed INS^+^ cells within the ductal lining ([Figure 5](#fig5){ref-type="fig"}B). Organoids derived from each donor (n = 8) were able to generate 1.5% ± 0.2% INS^+^ cells within the ductal lining (n = 8; [Figure 5](#fig5){ref-type="fig"}B). No difference in the proportion of INS^+^ cells was observed in the hyperglycemic animals ([Figure 5](#fig5){ref-type="fig"}C). Production of insulin was confirmed by immunostaining of C-peptide in INS^+^ cells (CPEP) ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Furthermore, insulin was co-expressed with several functional endocrine markers (PDX1, IAPP, NKX6.1, and SYP) but not with GCG ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5E). The differentiation phase *in vitro* was necessary for the appearance of INS^+^ cells as transplantation of organoids 1 week after expansion yielded either no grafts or only large cystic structures with no hormone-positive cells (data not shown).Figure 5Human Pancreatic Organoids Generate Insulin-Producing Cells *In Vivo*Grafts composed of *in vitro* differentiated organoids derived from islet-depleted exocrine pancreatic tissue were transplanted under the mouse kidney capsule after 7 days of expansion and 7 days of differentiation.(A) Day 1 after transplantation. Immunostaining for KRT19 (green) and INS (red). No INS^+^ cells are present. DAPI (blue) was used as nuclear counterstain. Scale bar, 50 μm.(B) Day 30 after transplantation. Transplanted organoids formed a ductal network (KRT19, green) and many INS^+^ cells (red) are present within the ductal lining (arrows indicate INS+ cells). DAPI (blue) was used as nuclear counterstain. Scale bar, 50 μm.(C) Percentage of INS^+^ cells in the ductal lining 1 month after transplantation. For each donor, grafts were transplanted in both normoglycemic and hyperglycemic mice, and two mice were transplanted per donor. No significant difference in the number of INS^+^ cells between the two groups of mice was found. Mean ± SEM, n = 8 donors.(D) Human C-peptide concentration after a glucose challenge in mice 1 month after organoid transplantation. Grafts were transplanted in either normoglycemic mice or hyperglycemic mice, and two mice were transplanted per donor. No significant difference in human C-peptide concentration between the two groups of mice was observed. Mean ± SEM, n = 8 donors.(E) Confocal image of a graft of sorted ALDH^hi^ cells isolated from organoids after expansion for 7 days. The ALDH^hi^ cells were differentiated for 7 days *in vitro* before transplantation under the kidney capsule of normoglycemic mice (n = 3 donors, 1 mouse per donor). The graft was retrieved after 50 days and contained both KRT19^+^ and CPEP^+^ cells. Cells co-expressing KRT19 and C-peptide indicate a transition stage from a duct (-like) phenotype to a β (-like) cell phenotype. DAPI (blue) was used as nuclear counterstain. Scale bar, 50 μm.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Human C-peptide could be readily measured in normoglycemic and hyperglycemic mice after a glucose challenge indicating that human insulin was released into the circulation upon a common β cell stimulus ([Figure 5](#fig5){ref-type="fig"}D). Basal human C-peptide was also present in normoglycemic mice before the glucose challenge (89.2 ± 59.9 pmol/L, n = 8). Blood glucose of grafted mice did not decrease significantly in either hyperglycemic mice (26.5 ± 3.9 mmol/L at day 0 versus 24.3 ± 3.8 mmol/L at day 30, n = 8) or in the normoglycemic group (8.6 ± 1.3 mmol/L at day 0 versus 6.7 ± 2.4 mmol/L at day 30, n = 8). Thus, graft function was detectable but not sufficient to restore normoglycemia within 1 month after organoid transplantation in hyperglycemic mice.

Sorted ALDH^hi^ cells derived from organoids expanded for 7 days were also differentiated for 1 week *in vitro* and subsequently transplanted under the kidney capsule of normoglycemic immunodeficient mice. After 50 days, retrieved grafts contained both KRT19^+^ and C-peptide^+^ cells ([Figure 5](#fig5){ref-type="fig"}E).

Discussion {#sec3}
==========

Our data indicate that adult human pancreatic tissue can be expanded as 3D organoids and long-term expansion can be achieved by passaging these pancreatic organoids. Cryopreservation of the pancreatic tissue is possible without losing these characteristics. A subpopulation of cells from the organoids have progenitor characteristics and give rise to endocrine cells after transplantation.

Progress to expand human adult pancreatic tissue and thus exploration of its capacity for endocrine cell differentiation has been hampered by epithelial-to-mesenchymal transition in 2D culture systems. The 3D culture system we have developed here provides an environment that allows substantial growth of human pancreatic cells starting from minced tissue. Recently we showed that adult mouse pancreatic organoids can also be expanded using similar culture conditions ([@bib18]). We and others described Matrigel-based culture methods for expansion of dispersed exocrine cells from adult mouse ([@bib18], [@bib24]) and human ([@bib4]) pancreas and for expansion of genetically modified human pancreatic ductal cells ([@bib31]). The striking aspect of our expansion protocol is the self-organization of the tissue into organoids with complex budding structures. These organoids display a remarkable KRT19^+^ epithelial tree-like structure with apical-basal polarity. This configuration has been shown for mouse embryonic pancreas tissue *in vivo* and *in vitro* ([@bib15], [@bib52]), and is present during human pancreatic organogenesis ([@bib23]). Similar culture systems enabled the expansion of human intestine and stomach in complex cell configurations, also called organoids, that appear to recapitulate organogenesis and tissue regeneration ([@bib45], [@bib3]).

During embryogenesis, the tip regions of the expanding ductal trees in the developing pancreas harbor progenitor cells ([@bib52], [@bib23], [@bib48]); and, in adult human tissue, we predicted, from single-cell transcriptome data, that the progenitor population in human adult pancreatic cells resides among the ductal population ([@bib16]). The morphology of the pancreatic organoids (derived from adult pancreatic tissue) in our study allowed us to search for putative progenitors in the budding structures. ALDH^hi^ cells had differentially high expression of the progenitor markers *PDX1*, *CPA1*, *MYC*, and *PTF1A* ([@bib52]). In addition, we established organoid culture from human fetal pancreatic tissue. These fetal pancreatic organoids also contained ALDH^hi^ cells in budding structures. Interestingly, transcriptional profiling revealed that ALDH^hi^ cells from adult pancreatic organoids were closer to ALDH^hi^ cells from fetal pancreatic organoids than to adult exocrine tissue (i.e., the islet-depleted tissue before expansion). This indicates a reprogramming of a subset of adult pancreatic cells to a progenitor-like stage.

Organoids expanded from human pancreas and transplanted in immunodeficient mice gave rise to insulin-producing cells after 1 month. The location of the insulin-producing cells in the grafts, i.e., in close proximity of or within the ductal lining, and the increased number of insulin-positive cells after engraftment compared with the initial cell population, support the concept that these cells were newly generated. However, while human C-peptide could be detected in the circulation the number of β cells was not sufficient to restore normoglycemia in diabetic mice 1 month after transplantation. In a recent study by [@bib31], the authors also showed that a subpopulation of expanded ductal cells could differentiate to insulin-secreting cells using an alternative approach of adenovirus-mediated expression of pro-endocrine factors and co-transplantation with mouse embryonic fibroblasts. In summary, although culture conditions need to be optimized to increase graft efficacy, our study provides a proof-of-concept that this 3D culture system can be used to expand primary human ductal cells that can differentiate to an endocrine fate without the need for genetic modification.

The origin of the ALDH^hi^ cells in our system is unclear. An ALDH^hi^ progenitor cell population has been identified in a subset of adult ductal/CAC cells ([@bib42]) and in the developing pancreas ([@bib22]) of mice, and these cells had the ability to self-renew and to differentiate into both endocrine and exocrine cells.

Notably, several studies have recently attributed a functional role to ALDH1 isoforms during pancreas development in humans ([@bib32]), mice ([@bib37]), and zebrafish ([@bib34]). Our data indicate that the specific culture conditions we developed support this progenitor state. Whether these ALDH^hi^ cells have a CAC origin or not warrants further investigation. At present this question is challenging as there is a lack of markers specific for human adult CACs. In mature murine pancreas, HES1 expression marks terminal ductal or CACs, whereas it identifies MPCs in early embryonic pancreas (until e11.5), and exocrine-restricted progenitors from e13.5 until birth ([@bib27]). Here, we found that *HES1* was slightly upregulated at the mRNA level in ALDH^hi^ cells, but HES1 protein expression was not restricted to the tips of the budding structures where the majority of ALDH^hi^ cells reside. Finally, the ALDH^hi^ population is heterogeneous, with only a small proportion of cells able to expand *in vitro*. Therefore, additional cell surface markers will be necessary to efficiently enrich and characterize the progenitor subpopulation from this heterogeneous population of ALDH^hi^ cells.

It has been unclear whether an endocrine/multipotent progenitor population exists in the adult human pancreas. Indeed, classical definitions of what constitutes an adult stem cell population are under debate ([@bib8]). However, we provide a proof-of-concept for the existence of a ALDH^hi^ population of human pancreatic cells (most likely KRT19^+^ cells) that appears under specific culture conditions, and that has the capacity to differentiate into an endocrine cell phenotype. Aldefluor has been used to detect ALDH^hi^ stem/progenitor cells in multiple tissues ([@bib2]). Here, we show that this cell population expresses the pancreatic progenitor markers *CPA1*, *PDX1*, *MYC*, and *PTF1A*. Furthermore, the gene expression profile of adult pancreatic ALDH^hi^ population presents a high degree of similarity with fetal pancreatic ALDH^hi^ cells.

Finally, since these cells are derived from the adult human pancreas and, thus, have already committed to a pancreatic fate, differentiation to the β cell lineage may be easier to achieve than differentiation of other adult stem/progenitor cells. In current allogeneic and autologous islet transplantation contaminating non-islet cells from the human pancreas are always co-transplanted with islets into human recipients without adverse effects ([@bib20]). Therefore, expanded and differentiated adult human pancreatic cells are likely to be relatively safe compared with embryonic or induced pluripotent cell lines for future β cell replacement therapy programs.

Experimental Procedures {#sec4}
=======================

Human Primary Tissue {#sec4.1}
--------------------

### Adult Pancreatic Tissue {#sec4.1.1}

Islet-depleted pancreatic tissue and human islets that could not be used for clinical transplantation were used in the studies according to national laws and if research content was available.

### Fetal Pancreatic Tissue {#sec4.1.2}

Fetal pancreatic tissue from elective abortions was used after written (parental) informed consent was provided. Collection and use of human fetal tissue for research was approved by the Medical Ethics committee of the LUMC.

Generation of Human and Fetal Pancreatic Organoids {#sec4.2}
--------------------------------------------------

Human adult islet-depleted pancreatic tissue was obtained after human islet isolation procedures. For culture of adult pancreatic organoids, small pieces of exocrine tissue were plated and expanded in Matrigel (BD Biosciences). Human fetal pancreatic tissue was obtained from fetuses with a gestational age of 9, 20, and 22 weeks. For culture of fetal pancreatic organoids, small pieces of human fetal pancreatic tissue were plated and expanded in Matrigel similar to adult pancreatic organoids. A progenitor population within the organoids was identified using the Aldefluor fluorescent reagent system (STEMCELL), which is based on detection of high ALDH activity in progenitor cells. ALDH^hi^ and ALDH^lo^ cell populations were sorted and plated in Matrigel before analysis. Human and fetal pancreatic organoids were analyzed by immunohistochemistry, RNA sequencing, qPCR, and smFISH, For a detailed description see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

*In Vitro* and *In Vivo* Differentiation of Human Pancreatic Organoids {#sec4.3}
----------------------------------------------------------------------

After expansion, adult pancreatic organoids were retrieved from the Matrigel and analyzed, cryopreserved in liquid nitrogen, or transferred to a differentiation culture medium (3 mL), characterized by absence of growth factors, in six-well hydrophobic plates (Corning). Organoids were cultured for 7--18 days before analysis or transplantation under the kidney capsule in normoglycemic or hyperglycemic immunodeficient mice. Human C-peptide was measured and grafts were analyzed up to 1 month after transplantation. For a detailed description see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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